Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma

Health-related quality of life was a secondary endpoint in the phase III GALLIUM study in previously untreated patients with follicular lymphoma who were treated with rituximab- or obinutuzumab-chemotherapy. Patients were randomized 1:1 to receive induction therapy with obinutuzumab- or rituximab-ch...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Hematol
Hauptverfasser: Davies, Andrew, Trask, Peter, Demeter, Judit, Florschütz, Axel, Hänel, Mathias, Kinoshita, Tomohiro, Pettengell, Ruth, Quach, Hang, Robinson, Stephen, Sadullah, Shalal, Sancho, Juan-Manuel, Udvardy, Miklos, Witzens-Harig, Mathias, Knapp, Andrea, Liu, Wenxin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7683459/
https://ncbi.nlm.nih.gov/pubmed/32314038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04021-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge